Literature DB >> 21459674

Mucosal-associated invariant T cells: unconventional development and function.

Lionel Le Bourhis1, Lucia Guerri, Mathilde Dusseaux, Emmanuel Martin, Claire Soudais, Olivier Lantz.   

Abstract

Mucosal-associated invariant T (MAIT) cells are a population of T cells that display a semi-invariant T cell receptor (TCR) and are restricted by the evolutionarily conserved major histocompatibility complex related molecule, MR1. Here, we review recent knowledge of this T cell population. MAIT cells are abundant in human blood, gut and liver, and display an effector phenotype. They follow an atypical pathway of development and preferentially locate to peripheral tissues. Human and mouse MAIT cells react to bacterially infected cells in an MR1-dependent manner. They migrate to the infection site and can be protective in experimental infection models. MAIT cells secrete interferon-γ, and interleukin-17 under certain conditions. The species conservation, as well as the wide microbial reactivity, infer an important role for this cell population in immunity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459674     DOI: 10.1016/j.it.2011.02.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  98 in total

Review 1.  Making memory at birth: understanding the differentiation of natural killer T cells.

Authors:  Isaac Engel; Mitchell Kronenberg
Journal:  Curr Opin Immunol       Date:  2012-02-02       Impact factor: 7.486

Review 2.  Innate-like lymphocytes in intestinal infections.

Authors:  Michael S Bennett; June L Round; Daniel T Leung
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

Review 3.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

4.  Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.

Authors:  N-E Serriari; M Eoche; L Lamotte; J Lion; M Fumery; P Marcelo; D Chatelain; A Barre; E Nguyen-Khac; O Lantz; J-L Dupas; E Treiner
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

Review 5.  Molecules in medicine mini review: the αβ T cell receptor.

Authors:  Eric T Clambey; Bennett Davenport; John W Kappler; Philippa Marrack; Dirk Homann
Journal:  J Mol Med (Berl)       Date:  2014-05-22       Impact factor: 4.599

Review 6.  Regional specialization within the intestinal immune system.

Authors:  Allan M Mowat; William W Agace
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

7.  Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

Authors:  Isabelle Magalhaes; Karine Pingris; Christine Poitou; Stéphanie Bessoles; Nicolas Venteclef; Badr Kiaf; Lucie Beaudoin; Jennifer Da Silva; Omran Allatif; Jamie Rossjohn; Lars Kjer-Nielsen; James McCluskey; Séverine Ledoux; Laurent Genser; Adriana Torcivia; Claire Soudais; Olivier Lantz; Christian Boitard; Judith Aron-Wisnewsky; Etienne Larger; Karine Clément; Agnès Lehuen
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

8.  The Toll-like receptor 9 signalling pathway regulates MR1-mediated bacterial antigen presentation in B cells.

Authors:  Jianyun Liu; Randy R Brutkiewicz
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

9.  Unusual evolutionary conservation and further species-specific adaptations of a large family of nonclassical MHC class Ib genes across different degrees of genome ploidy in the amphibian subfamily Xenopodinae.

Authors:  Eva-Stina Edholm; Ana Goyos; Joseph Taran; Francisco De Jesús Andino; Yuko Ohta; Jacques Robert
Journal:  Immunogenetics       Date:  2014-04-27       Impact factor: 2.846

10.  Will loss of your MAITs weaken your HAART [corrected]?

Authors:  Johan K Sandberg; Joana Dias; Barbara L Shacklett; Edwin Leeansyah
Journal:  AIDS       Date:  2013-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.